Thank you.
I'll just follow up on my earlier comments and put together a few things. We've been talking a bit about the challenge of vaccine hesitancy and some of the efforts to combat that. That's in a context, bluntly, where two-thirds of Canada's physical contribution to COVAX has been of a kind of vaccine that's not recommended for use in Canada.
To clarify my comments about Sinopharm and Sinovac, according to Dr. Bruce Aylward with the WHO, Sinopharm and Sinovac COVID vaccines have been shipped to 49 countries through COVAX, accounting for nearly 20% of total vaccines shipped through COVAX.
Do you think the problem of vaccine hesitancy in developing countries is exacerbated by sending vaccines that are known to have lower efficacy than other vaccines or that aren't recommended for use in the country that's sending them? Do you think that's contributing to vaccine hesitancy?